Cure Activism 101

Destination: Cure First Steps You’d like to get involved in cure activism—where do you start? by Jeannie Wraight If you’d like to help in the fight to find...

Vpu Inhibitor Candidate

BIT225 is a new type of antiviral called a Vpu inhibitor, which researchers are investigating to treat both HIV and HIV/hepatitis C (HCV) co-infection....

Orphaned Vaccines

Sometimes viewing a complex issue in its most simplistic form can help us to understand where a problem lies. HIV is a virus that...

Broad Spectrum Antivirals: Part I

Spectrum Analysis Broad spectrum antivirals shift the drug model paradigm by Jeannie Wraight The recent spread of emerging pandemic viruses such as Zika and Ebola has increased...

HIV Remission Studies & Starting ARVs Early

Step by Step At CROI 2017, HIV remission studies focus on early antiretroviral therapy initiation by Jeannie Wraight This year marked the 24th annual Conference on Retroviruses...

amfAR Institute for HIV Cure Research: An Interview with Dr. Paul...

Hide & Seek Paul Volberding, MD, helps create synergy at the amfAR Institute for Cure Research by Jeannie Wraight The amfAR Institute for HIV Cure Research was...

Imbokodo Study Launches

The Strength of Women The Imbokodo Study launches in Southern Africa by Jeannie Wraight In Zulu, the word “Imbokodo” means “rock” and is part of a well-known...

Novel Cure Research Supported by amfAR

Deciphering the Puzzle A new round of amfAR's Countdown to a Cure initiative grants support novel cure research by Jeannie Wraight amfAR has awarded a new round...

David Evans

Risk & Reward Activist David Evans weighs in on next steps in cure advocacy & research by Jeannie Wraight In the late 1980s and throughout the ’90s,...

The New Administration & the Threat to HIV Care and Cure...

Buyer Beware The new administration may threaten HIV care and cure research by Jeannie Wraight Our way of life in the U.S. has already drastically changed as...

LATEST POSTS

An Aspirin A Day May Keep HIV Away

The Journal of the International AIDS Society (JIAS) has published the results of a study conducted by researchers from the universities of Manitoba, Waterloo...

Pride In Spite of It All

Let’s Talk About PrEP